JP2022537453A5 - - Google Patents
Info
- Publication number
- JP2022537453A5 JP2022537453A5 JP2021576300A JP2021576300A JP2022537453A5 JP 2022537453 A5 JP2022537453 A5 JP 2022537453A5 JP 2021576300 A JP2021576300 A JP 2021576300A JP 2021576300 A JP2021576300 A JP 2021576300A JP 2022537453 A5 JP2022537453 A5 JP 2022537453A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- oncodriver
- pulsed
- combination therapy
- dendritic cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962865027P | 2019-06-21 | 2019-06-21 | |
| US62/865,027 | 2019-06-21 | ||
| PCT/US2020/038719 WO2020257640A1 (en) | 2019-06-21 | 2020-06-19 | Combination therapy with semaphorin-4d blockade (sema4d) and dc1 therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022537453A JP2022537453A (ja) | 2022-08-25 |
| JP2022537453A5 true JP2022537453A5 (https=) | 2023-05-30 |
| JP7579284B2 JP7579284B2 (ja) | 2024-11-07 |
Family
ID=71575807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576300A Active JP7579284B2 (ja) | 2019-06-21 | 2020-06-19 | セマフォリン４ｄ遮断（ｓｅｍａ４ｄ）とｄｃ１療法との併用療法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11660330B2 (https=) |
| EP (1) | EP3986446A1 (https=) |
| JP (1) | JP7579284B2 (https=) |
| KR (1) | KR20220044490A (https=) |
| CN (1) | CN114364399A (https=) |
| AU (1) | AU2020297592A1 (https=) |
| BR (1) | BR112021025795A2 (https=) |
| IL (1) | IL288779B2 (https=) |
| MX (1) | MX2021015970A (https=) |
| WO (1) | WO2020257640A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230390345A1 (en) * | 2020-08-21 | 2023-12-07 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Combination therapy comprising her-2-dc1 vaccine, a probiotic, and semaphorin |
| WO2024159101A1 (en) * | 2023-01-26 | 2024-08-02 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Methods for identifying disseminated cancer cells in breast cancer patients |
| WO2024159105A1 (en) * | 2023-01-26 | 2024-08-02 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Methods of treating cancer comprising administration of intratumoral dcs in combination with systemic igg monoclonal antibody |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1601438A (https=) | 1968-10-17 | 1970-08-24 | ||
| US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DE69120146T2 (de) | 1990-01-12 | 1996-12-12 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| DE69133557D1 (de) | 1990-08-29 | 2007-03-15 | Pharming Intellectual Pty Bv | Homologe rekombination in säugetier-zellen |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| FR2686087A1 (fr) | 1992-01-13 | 1993-07-16 | Inst Nat Sante Rech Med | Nouvel antigene lymphocytaire, anticorps correspondant et leurs applications. |
| US5652138A (en) | 1992-09-30 | 1997-07-29 | The Scripps Research Institute | Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| ATE183513T1 (de) | 1993-06-03 | 1999-09-15 | Therapeutic Antibodies Inc | Herstellung von antikörperfragmenten |
| US6180377B1 (en) | 1993-06-16 | 2001-01-30 | Celltech Therapeutics Limited | Humanized antibodies |
| US6130364A (en) | 1995-03-29 | 2000-10-10 | Abgenix, Inc. | Production of antibodies using Cre-mediated site-specific recombination |
| US6410690B1 (en) | 1995-06-07 | 2002-06-25 | Medarex, Inc. | Therapeutic compounds comprised of anti-Fc receptor antibodies |
| FR2765243B1 (fr) | 1997-06-30 | 1999-07-30 | Usinor | Acier inoxydable austenoferritique a tres bas nickel et presentant un fort allongement en traction |
| US7919594B2 (en) | 2007-02-14 | 2011-04-05 | Vaccinex, Inc. | Human anti-CD100 antibodies |
| WO2010129917A2 (en) | 2009-05-08 | 2010-11-11 | Vaccinex, Inc. | Anti-cd100 antibodies and methods for using the same |
| BR112015032690B1 (pt) | 2013-06-25 | 2020-03-10 | Vaccinex, Inc. | Uso de moléculas inibidoras de semaforina-4d em combinação com uma terapia imunomoduladora para inibir o crescimento tumoral e metástase |
| CA2942721A1 (en) * | 2014-03-14 | 2015-09-17 | Czerniecki, Brian J. | Methods for monitoring cd4+ t-helper type 1 response in cancer and immune restoration |
| CA2955445A1 (en) * | 2014-07-17 | 2016-01-21 | Brian J. Czerniecki | Manufacturing of multi-dose injection ready dendritic cell vaccines and combination therapy for blocking her2 and her3 |
| JP2018515421A (ja) * | 2015-05-22 | 2018-06-14 | ブライアン ジェイ ツェルニキＣＺＥＲＮＩＥＣＫＩ， Ｂｒｉａｎ， Ｊ． | 複数用量注射準備済樹状細胞ワクチンの製造 |
-
2020
- 2020-06-19 IL IL288779A patent/IL288779B2/en unknown
- 2020-06-19 AU AU2020297592A patent/AU2020297592A1/en active Pending
- 2020-06-19 WO PCT/US2020/038719 patent/WO2020257640A1/en not_active Ceased
- 2020-06-19 US US16/906,713 patent/US11660330B2/en active Active
- 2020-06-19 JP JP2021576300A patent/JP7579284B2/ja active Active
- 2020-06-19 EP EP20739526.0A patent/EP3986446A1/en active Pending
- 2020-06-19 KR KR1020227002169A patent/KR20220044490A/ko active Pending
- 2020-06-19 BR BR112021025795A patent/BR112021025795A2/pt unknown
- 2020-06-19 CN CN202080045550.9A patent/CN114364399A/zh active Pending
- 2020-06-19 MX MX2021015970A patent/MX2021015970A/es unknown
-
2023
- 2023-04-27 US US18/307,920 patent/US12201719B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jain et al. | Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms | |
| Saif et al. | Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer | |
| JP2022537453A5 (https=) | ||
| JP4729503B2 (ja) | 抗癌剤の奏効率増強剤 | |
| Gani et al. | In vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: An exploration of the therapeutic ratio | |
| JP2013505223A5 (https=) | ||
| US10987336B2 (en) | Method of preventing or treating side effect of tumor therapy | |
| JP2019501204A5 (https=) | ||
| JP2008528486A5 (https=) | ||
| JP2008501630A6 (ja) | 抗癌剤の効果増強剤 | |
| JP2009539870A5 (https=) | ||
| JP2018537975A5 (https=) | ||
| Zhu et al. | Hydrogen inhibits the proliferation and migration of gastric cancer cells by modulating lncRNA MALAT1/miR-124-3p/EZH2 axis | |
| CN105120663A (zh) | 用于利用羧胺三唑乳清酸盐治疗对先前化学治疗药物和靶向药物具有获得性耐药性的癌症的方法和组合物 | |
| Irene et al. | The emergence of targetable pathways in colorectal cancer | |
| Du et al. | Gantt chart for updated OS and PFS after cancer targeted therapy | |
| JP2014510047A5 (https=) | ||
| Freres et al. | Categories of anticancer treatments | |
| JP2023512276A5 (https=) | ||
| Joensuu et al. | A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancer | |
| NO20045249L (no) | Epotilonderivat for behandling av hepatom og andre kreftsykdommer | |
| RU2019134769A (ru) | Композиции для лечения резистентных к лекарственным средствам опухолей и способы их применения | |
| Ooi et al. | RAS and BRAF genes as biomarkers and target for personalised colorectal cancer therapy: An update | |
| Częścik et al. | Evolution or Revolution in Colorectal Cancer Treatment: Present and Future of New Therapeutic Options. A Narrative Review | |
| Liu et al. | Biomimetic anlotinib-loaded FePc-silicate nanoparticles for sonodynamic and immunotherapy in non-small cell lung cancer via dual PD-L1 modulation |